Holy Cross Cancer Blog

Do you or someone you know have metastatic or locally advanced breast cancer?

  • Posted Nov 25, 2014
  • hchadmin

Find out if you qualify


Breast cancer is diagnosed in more than 1.3 million women worldwide each year and is the leading cause of cancer-related death in women. It is estimated that at least 5 percent of breast cancer cases result from inherited mutations or alterations in BRCA1 and BRCA2 genes. Women with these mutations have a lifetime risk of developing breast cancer of 40-85 percent. Males with BRCA2 mutations also carry an increased risk of breast cancer. The Brocade 3 study is a research study for men and women with HER-2 negative metastatic or locally advanced BRCA-associated breast cancer.

This research study is currently seeking female and male volunteers, ages 18 and older, who have been diagnosed with HER-2 negative metastatic or locally advanced BRCA-associated breast cancer. The purpose of this research study is to evaluate the safety and effectiveness of an investigational drug, veliparib (or placebo), in combination with two chemotherapeutic drugs that are commonly used for the treatment of breast cancer.

Compensation for travel may be provided. More information on this study can be found by visiting www.Brocade3Study.com to see if you may qualify.


Breast Cancer Survivor Celebration on Sept. 17

  • Posted Sep 04, 2014
  • hchadmin

On September 17th the American Cancer Society is hosting a Survivor Celebration at Seminole Classic Casino in Hollywood. They are extending an invitation to any breast cancer survivors within the Holy Cross community. Please see the attached invitation and feel free to pass it on. Space is limited so please RSVP. Have a wonderful day and thank you for all that you do in the fight against breast cancer!

image: 

Join us to make strides against breast cancer

  • Posted Sep 04, 2014
  • hchadmin

You are invited to attend Team Holy Cross' Making Strides Against Breast Cancer kickoff meeting today at 5 PM in the Cancer Center's ground floor reception area! Since last year's MSABC walk, many of our own Associates, family members and friends have been touched by breast cancer. We have the opportunity to make a difference and to help people get well, stay well, find cures and fight back with our partners at the American Cancer Society.The walk will be held at Huizenga Park on Saturday, October 11. If you have any questions, please feel free to call Maureen Mann at 954-351-5955.

image: 

Stand Up to Cancer on September 5

  • Posted Aug 22, 2014
  • hchadmin

STAND UP TO CANCER – The momentum continues to build for our groundbreaking Stand Up To Cancer campaign. We are currently at 57-percent of our needed registered attendees. If you haven’t registered yet, don’t worry – there’s still time to take action and help us reach our goal by attending at Holy Cross Hospital’s Auditorium on Friday 9/5/14 at 7PM. You might end up being on national TV!!


The admission fee is now $15 and does not include a t-shirt but a limited supply of shirts will be available at the parties for a small donation. Supporters will also have the opportunity to donate $10 for our first ever virtual luminaria bag that can be used as a Facebook profile picture. Visit standup2finishthefight.org to make a donation for a virtual luminaria. All proceeds will go directly to funding our research Dream Team that will focus on lung cancer, the leading cancer killer in the United States.


You can also help by forwarding this information to your friends and family to encourage their participation.


Oncologist Stephen Patterson, MD, Honored

  • Posted Jun 12, 2014
  • Christine Walker

Stephen Patterson, MD, was honored earlier this month by the Fort Lauderdale Rotary Foundation with the organization’s highest award, The Paul Harris Fellow Award, for his work in the community.  This was a family affair as Dr. Patterson’s father received the same recognition earlier in his career.  While his father presented him with the plaque,  his mother pinned him with the gold Harris Fellow pin.

 

categories: 

Cancer Research Success Story

  • Posted May 13, 2014
  • hchadmin

It is a privilege to work with our patients who volunteer to participate in cancer research clinical trials. We feel great pride when one of the drugs studied at Holy Cross Hospital generates positive data to attain FDA approval and therefore help many more patients across the country.

Ipilimumab is an immunotherapy treatment for metastatic melanoma and was on trial here at Holy Cross. It received FDA approval for treatment of unresectable metastatic melanoma and is commercially available under the name Yervoy.

Holy Cross opened the study of Ipilimumab in 2008 under the leadership of Dr Ena Segota. Janet Copen, RN, BSN was the study coordinator. The study was sponsored by Bristol-Myers Squibb and our study site just closed.

The study was designed for patients with stage III or IV unresectable metastatic melanoma. The five year survival rate for stage IV melanoma is only about 15% to 20% (American Cancer Society http://www.cancer.org/cancer/skincancer-melanoma/detailedguide/melanoma-...) .

One of our patients continues to benefit well over three and a half years after enrollment. He recently stopped by to visit cancer center staff and expressed how happy he is. We are sharing with you how happy we are for him and other patients who can benefit from this treatment.

Susan Jones
Regulatory Coordinator, Bienes Cancer Center and Orthopedic Institute


Pages


About the Center

The Michael & Dianne Bienes Comprehensive Cancer Center in Fort Lauderdale, Florida is the Cancer Care Leader in Broward County. Dedicated to providing patients with precise diagnosis, the latest and most advanced treatment and aftercare options, we offer a multidisciplinary approach to care, a compassionate and spiritual healing environment, and an affiliation with the National Cancer Institute. We are also working together with Massachusetts General Hospital Cancer Center to provide South Florida residents with rapid access to specialized cancer care and genetics counseling.

Blog Categories

Blog Archive